BACTERIAL
IMMUNOTHERAPY

Bacterial immunotherapy treatments are prescribed for the treatment and prevention of infectious bacterial diseases. This type of treatment stimulates the production of antibodies, providing an adequate defence system against bacterial infection.

The bacterial vaccines marketed by ITAI pharma consist of inactivated and standardised bacterial cell suspensions, which are manufactured from one or more bacterial strains obtained from the culture of the sample taken from the patient by the specialist (autovaccine mode).

The bacterial immunotherapy treatments marketed by ITAI pharma are individualised medicinal products. This means that they will need to be prescribed by a specialist doctor, who will determine the type and duration of the treatment and the administration schedule.

If in doubt, ITAI pharma recommends consulting a specialist who will help you to better understand and interpret the information contained herein.

Bacterial immunotherapy treatments marketed by ITAI pharma S.L.

  • ITAI SUBLINGUAL BACTERIAL AUTOVACCINE

  • ITAI SUBLINGUAL BACTERIAL AUTOVACCINE PLUS 2

  • URITAI SUBLINGUAL BACTERIAL AUTOVACCINE

ITAI SUBLINGUAL BACTERIAL AUTOVACCINE: Suspension for sublingual administration in spray form. It is an individualised medicine manufactured from cells of 1 or 2 bacterial species (immunising agents) isolated from the culture of the sample(s) taken from the patient from the site/focus of infection, inactivated and standardised.

ITAI SUBLINGUAL BACTERIAL AUTOVACCINE PLUS 2: Suspension for sublingual administration in spray form. It is an individualised medicine manufactured from cells of 2 bacterial species (immunising agents) isolated from the culture of the sample(s) taken from the patient from the site/focus of infection, inactivated and standardised.

URITAI SUBLINGUAL BACTERIAL AUTOVACCINE: Suspension for sublingual administration in spray form. It is an individualised medicine manufactured from cells of 1 or 2 bacterial species (immunising agents) isolated from the culture of the sample(s) taken from the patient from the site/focus of infection, inactivated and standardised.